SODIUM CHLORIDE injection, solution USA - engelsk - NLM (National Library of Medicine)

sodium chloride injection, solution

b. braun medical inc. - sodium chloride (unii: 451w47iq8x) (sodium cation - unii:lyr4m0nh37, chloride ion - unii:q32zn48698) - sodium chloride 9 mg in 1 ml - this intravenous solution is indicated for use in adults and pediatric patients as a source of electrolytes and water for hydration. this product is designed for use as a diluent and delivery system for intermittent intravenous administration of compatible drug additives. consult prescribing information for indications and usage  of drug additives to be administered in this manner. this solution is contraindicated where the administration of sodium or chloride could be clinically detrimental.

DAFALGAN CODEINE, comprimé effervescent sécable Frankrike - fransk - ANSM (Agence Nationale de Sécurité du Médicament et des Produits de Santé)

dafalgan codeine, comprimé effervescent sécable

upsa sas - codéine (phosphate de) 0; paracétamol 0 - comprimé - 0,0300 g - pour un comprimé > codéine (phosphate de 0,0300 g > paracétamol 0,500 g - antalgique peripherique / analgesique opioide - classe pharmacothérapeutique : antalgique peripherique / analgesique opioide - code atc : n02be51.ce médicament contient du paracétamol et de la codéine : c'est un antalgique (calme la douleur).la codéine appartient à un groupe de médicaments appelés les antalgiques opioïdes qui agissent pour soulager la douleur. elle peut être utilisée seule ou en association avec d’autres antalgiques comme le paracétamol.ce médicament peut être utilisé chez les adultes et les enfants de plus de 12 ans sur une courte durée pour des douleurs modérées non soulagées par d’autres antalgiques comme le paracétamol ou l’ibuprofène utilisés seuls.vous devez vous adresser à votre médecin si vous ne ressentez aucune amélioration ou si vous vous sentez moins bien après 3 jours.

SODIUM CHLORIDE INJECTION 0.9% Israel - engelsk - Ministry of Health

sodium chloride injection 0.9%

teva medical ltd - sodium chloride - solution for injection - sodium chloride 0.9 g / 100 ml - sodium chloride - sodium chloride - a source of water and electrolytes. also indicated for use as priming solutions in hemodialysis procedures.

SODIUM IODIDE (I-131) CAPSULE T Israel - engelsk - Ministry of Health

sodium iodide (i-131) capsule t

isorad ltd, israel - iodine sodium - capsules - iodine sodium 37 mbq - sodium iodide (131i) - sodium iodide (131i) - treatment of graves disease, toxic multinodular goite or autonomous nodules.treatment of papillary and follicular thyroid carcinoma including metastatic disease. sodium iodide (i-131) therapy is often combined with surgical intervention and with antithyroid medications.

Sodium Chloride Injection BP 0.9% New Zealand - engelsk - Medsafe (Medicines Safety Authority)

sodium chloride injection bp 0.9%

fresenius kabi new zealand limited - sodium chloride 0.9%;  ;   - solution for injection - 0.9 % - active: sodium chloride 0.9%     excipient: hydrochloric acid sodium hydroxide water for injection - sodium chloride injection bp 0.9% can be used as the vehicle for the restoration of electrolytes, as the vehicle for parenteral drug administration or as a sterile irrigation medium.

SODIUM CHLORIDE- sodium chloride injection USA - engelsk - NLM (National Library of Medicine)

sodium chloride- sodium chloride injection

fresenius kabi usa, llc - sodium chloride (unii: 451w47iq8x) (sodium cation - unii:lyr4m0nh37, chloride ion - unii:q32zn48698) - sodium chloride 9 mg in 1 ml - this parenteral preparation is indicated only for diluting or dissolving drugs for intravenous, intramuscular, or subcutaneous injection, according to instructions of the manufacturer of the drug to be administered.

SODIUM CHLORIDE injection USA - engelsk - NLM (National Library of Medicine)

sodium chloride injection

hikma pharmaceuticals usa inc. - sodium chloride (unii: 451w47iq8x) (sodium cation - unii:lyr4m0nh37, chloride ion - unii:q32zn48698) - sodium chloride 9 mg in 1 ml - this parenteral preparation indicated only for diluting or dissolving drugs for intravenous, intramuscular or subcutaneous injection, according to instructions of the manufacturer of the drug to be administered. 

SODIUM FLUORIDE F 18- sodium fluoride f-18 injection USA - engelsk - NLM (National Library of Medicine)

sodium fluoride f 18- sodium fluoride f-18 injection

ucsf radiopharmaceutical facility - sodium fluoride f-18 (unii: 9l75099x6r) (fluoride ion f-18 - unii:4m4we5n2ge) - fluoride ion f-18 200 mci in 1 ml - sodium fluoride f 18 injection is indicated for diagnostic positron emission tomography (pet) imaging of bone to define areas of altered osteogenic activity. none. pregnancy category c any radiopharmaceutical including sodium fluoride f 18 injection has a potential to cause fetal harm. the likelihood of fetal harm depends on the stage of fetal development, and the radionuclide dose. animal reproductive and developmental toxicity studies have not been conducted with sodium fluoride f 18 injection. prior to the administration of sodium fluoride f 18 injection to women of childbearing potential, assess for presence of pregnancy. sodium fluoride f 18 injection should be given to a pregnant woman only if clearly needed. it is not known whether sodium fluoride f 18 injection is excreted into human milk. because many drugs are excreted in human milk and because of the potential for serious adverse reactions in nursing infants, a decision should be made whether to interrupt nursing after administration of sodium fl

SODIUM FLUORIDE F 18- sodium fluoride f-18 injection USA - engelsk - NLM (National Library of Medicine)

sodium fluoride f 18- sodium fluoride f-18 injection

precision nuclear llc - sodium fluoride f-18 (unii: 9l75099x6r) (fluoride ion f-18 - unii:4m4we5n2ge) - fluoride ion f-18 200 mci in 1 ml - sodium fluoride f 18 injection usp is indicated for diagnostic positron emission tomography (pet) imaging of bone to define areas of altered osteogenic activity. none pregnancy category c any radiopharmaceutical including sodium fluoride f 18 injection has a potential to cause fetal harm. the likelihood of fetal harm depends on the stage of fetal development, and the radionuclide dose. animal reproductive and developmental toxicity studies have not been conducted with sodium fluoride f 18 injection. prior to the administration of sodium fluoride f 18 injection to women of childbearing potential, assess for presence of pregnancy. sodium fluoride f 18 injection should be given to a pregnant woman only if clearly needed. it is not known whether sodium fluoride f 18 injection is excreted into human milk. because many drugs are excreted in human milk and because of the potential for serious adverse reactions in nursing infants, a decision should be made whether to interrupt nursing after administration of sodium f

SODIUM FLUORIDE F 18 injection USA - engelsk - NLM (National Library of Medicine)

sodium fluoride f 18 injection

the university of utah dba cyclotron radiochemistry lab huntsman cancer institute - sodium fluoride f-18 (unii: 9l75099x6r) (fluoride ion f-18 - unii:4m4we5n2ge) - fluoride ion f-18 200 mci in 1 ml - sodium fluoride f 18 injection, usp is indicated for diagnostic positron emission tomography (pet) imaging of bone to define areas of altered osteogenic activity. none. pregnancy category c any radiopharmaceutical including sodium fluoride f 18 injection has a potential to cause fetal harm. the likelihood of fetal harm depends on the stage of fetal development, and the radionuclide dose. animal reproductive and developmental toxicity studies have not been conducted with sodium fluoride f 18 injection. prior to the administration of sodium fluoride f 18 injection to women of childbearing potential, assess for presence of pregnancy. sodium fluoride f 18 injection should be given to a pregnant woman only if clearly needed. it is not known whether sodium fluoride f 18 injection is excreted into human milk. because many drugs are excreted in human milk and because of the potential for serious adverse reactions in nursing infants, a decision should be made whether to interrupt nursing after administration of sodi